GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IR-Med IRME · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Forecasts

Analyst averages for the fiscal years ahead

FY2026
Revenue$31.5m
Revenue, highest$32.4m
Revenue, lowest$30.3m
Earnings per share0.17
Earnings per share, highest0.18
Earnings per share, lowest0.17
Analysts3

Earnings against forecasts

Earnings per share by fiscal quarter

Q1 2025Q3 2024Q2 2024Q1 2024Q4 2023
Forecast-0.02-0.01-0.01-0.02-0.02
Reported-0.00-0.01-0.01-0.02-0.02
Difference+80.5%0.0%0.0%0.0%+2.0%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

3 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 645.9%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.